Federal Register / Vol. 66, No. 250 / Monday, December 31, 2001 / Notices 67553

Internet electronic mail at

BJS1@NRC.GOV.

Dated at Rockville, Maryland, this 20th day

of December 2001.

For the Nuclear Regulatory Commission.

Brenda Jo. Shelton,

NRC Clearance Officer, Office of the Chief

Information Officer.

[FR Doc. 01–32060 Filed 12–28–01; 8:45 am]

BILLING CODE 7590–01–P

NUCLEAR REGULATORY

COMMISSION

Agency Information Collection

Activities: Proposed Collection;

Comment Request

AGENCY: Nuclear Regulatory

Commission (NRC).

ACTION: Notice of pending NRC action to

submit an information collection

request to OMB and solicitation of

public comment.

SUMMARY: The NRC is preparing a

submittal to OMB for review of

continued approval of information

collections under the provisions of the

Paperwork Reduction Act of 1995 (44

U.S.C. Chapter 35).

Information pertaining to the

requirement to be submitted:

1. The title of the information

collection: NRC Form 536, ‘‘Operator

Licensing Examination Data’’.

2. Current OMB approval number:

3150–0131.

3. How often the collection is

required: Annually.

4. Who is required or asked to report:

All holders of operating licenses or

construction permits for nuclear power

reactors.

5. The number of annual respondents:

80.

6. The number of hours needed

annually to complete the requirement or

request: 80.

7. Abstract: NRC is requesting

renewal of its clearance to annually

request all commercial power reactor

licensees and applicants for an

operating license to voluntarily send to

the NRC: (1) Their projected number of

candidates for operator licensing initial

examinations; (2) the estimated dates of

the examinations; (3) information on

whether the examination will be facility

developed or NRC developed; and (4)

the estimated number of individuals

that will participate in the Generic

Fundamentals Examination (GFE) for

that calendar year. Except for the GFE,

this information is used to plan budgets

and resources in regard to operator

examination scheduling in order to meet

the needs of the nuclear industry.

Submit, by March 1, 2002, comments

that address the following questions:

1. Is the proposed collection of

information necessary for the NRC to

properly perform its functions? Does the

information have practical utility?

2. Is the burden estimate accurate?

3. Is there a way to enhance the

quality, utility, and clarity of the

information to be collected?

4. How can the burden of the

information collection be minimized,

including the use of automated

collection techniques or other forms of

information technology?

A copy of the draft supporting

statement may be viewed free of charge

at the NRC Public Document Room, One

White Flint North, 11555 Rockville

Pike, Room O–1 F23, Rockville, MD

20852. OMB clearance requests are

available at the NRC worldwide web

site: http://www.nrc.gov/NRC/PUBLIC/

OMB/index.html. The document will be

available on the NRC home page site for

60 days after the signature date of this

notice.

Comments and questions about the

information collection requirements

may be directed to the NRC Clearance

Officer, Brenda Jo. Shelton, U.S. Nuclear

Regulatory Commission, T–6 E6,

Washington, DC 20555–0001, by

telephone at 301–415–7233, or by

Internet electronic mail at

BJS1@NRC.GOV.

Dated at Rockville, Maryland, this 21st day

of December 2001.

For the Nuclear Regulatory Commission.

Beth St. Mary,

Acting NRC Clearance Officer, Office of the

Chief Information Officer.

[FR Doc. 01–32064 Filed 12–28–01; 8:45 am]

BILLING CODE 7590–01–P

NUCLEAR REGULATORY

COMMISSION

[Docket No. 030–35994, License No. 37–

30603–01,EA–01–313]

In the Matter of Advanced Medical

Imaging and Nuclear Services Easton,

PA 18045; Order Suspending License

(Effective Immediately)

I

Advanced Medical Imaging and

Nuclear Services (Licensee) is the

holder of Byproduct Nuclear Material

License No. 37–30603–01 issued by the

Nuclear Regulatory Commission (NRC

or Commission) pursuant to 10 CFR

parts 30 and 35. License No. 37–30603–

01 authorizes possession and use of

certain byproduct material identified in

10 CFR 35.100 and 35.200 for any

uptake, dilution, excretion, imaging and

localization procedures approved in

those parts. The license was issued on

February 16, 2001, and is due to expire

on February 28, 2011.

II

On November 30, 2001, the NRC

commenced an inspection at the

Licensee’s facility in Easton,

Pennsylvania. Based on the findings of

the inspection to date, the NRC

identified violations of requirements.

The violations identified during the

inspection involved the possession and

use of radioactive materials (including

the diagnostic administration to

patients) from June 2001 to November

2001, even though the licensee did not

have an authorized user (AU) and/or a

Radiation Safety Officer (RSO) as

required by the regulations and the

license. The individual named on the

license as the RSO and AU between

February 16, 2001, and December 10,

2001, had neither been hired by the

licensee’s organization nor had ever

acted as the RSO or AU for the licensee.

After these violations were identified,

the NRC issued a Confirmatory Action

Letter to the licensee on December 3,

2001, which in part, confirmed the

Licensee’s commitment to immediately

place all byproduct material in its

possession in secured storage, and cease

all licensed activities until the Licensee

retained an AU and RSO, and received

approval from the NRC for the changes

requiring a license amendment to bring

the licensee’s program into full

compliance with 10 CFR Part 35. The

licensee submitted an amendment

request, and on December 11, 2001,

NRC issued an amendment to the

license, to reflect the new AU and RSO.

The Licensee subsequently conducted

activities without the supervision of the

AU as required by 10 CFR 35.25.

Specifically, shortly after the license

amendment was issued, byproduct

materials were ordered during the

evening hours of December 11, 2001,

and subsequently were received,

possessed, and used for administration

to patients on December 12, 2001, by an

individual who had not received the

required instructions from, and who

was not under the supervision of, an

AU. The individual was not provided

instructions from the AU in the

principles of radiation appropriate to

the individual’s use of byproduct

materials, including, but not limited to,

appropriate use of dosimetry, doses to

be administered to patients, and

procedures for radiation safety as

required by 10 CFR 35.25. This

constitutes an additional violation.

These violations are particularly

significant because (1) The individual